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GENETIC DISORDERS – DEVELOPMENT
Cloning and characterization of a novel gene promoting
ureteric bud branching in the metanephros1
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Cloning and characterization of a novel gene promoting ureteric
bud branching in the metanephros.
Background. The ureteric buds and metanephric mesenchy-
mal cells reciprocally induce each other’s maturation during kid-
ney development, and implicated transcription factors, secreted
growth factors, and cell surface signaling peptides are critical
regulators of renal branching morphogenesis. Protein kinase C
(PKC) is a key enzyme in the signal transduction mechanisms
in various biologic processes, including development, because
it regulates growth and differentiation. Inhibition of PKC by
the sphingolipid product ceramide interferes with nephron for-
mation in the developing kidney, but the molecule that controls
ureteric bud branching downstream of PKC is still unknown.
Methods. Differential display polymerase chain reaction
(PCR) of metanephroi cultured with a PKC activator and in-
hibitor was performed. We also examined the role of a novel
gene in kidney development with organ culture system.
Results. A novel gene encoding a 759 bp mRNA was identi-
fied, and we named it metanephros-derived tubulogenic factor
(MTF)/L47. Inhibition of MTF with antisense oligonucleotide
impaired ureteric bud branching by cultured metanephroi, and
addition of recombinant MTF protein promoted ureteric bud
branching in cultured metanephroi and increased cell prolifer-
ation.
Conclusion. We identified a novel molecule in developing
kidney that is capable of modulating ureteric bud branching
and kidney differentiation.
Ureteric bud branching is one of the most impor-
tant processes in renal organogenesis, and reciprocal
induction by ureteric bud and metanephric mesenchy-
mal cells is important for ureteric bud branching and
mesenchyme-to-epithelial conversion [1]. Undifferenti-
ated metanephric mesenchymal cells are rescued from
programmed cell death by a signal from the ureteric buds,
condense around the tip of the ureteric buds, become po-
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larized epithelium, and form vesicles. The vesicles then
elongate and differentiate to form the proximal nephron
in the kidney. The ureteric buds are in turn rescued from
degeneration by the signal from nephrogenic and stro-
mal progenitor mesenchyme, branch, and then elongate
to form collecting ducts.
In signal transduction mechanisms in various biologic
processes and in controlling gene expression during organ
development, protein kinase C (PKC), a serine/threonine
kinase, is recognized as a key enzyme [2, 3]. In addi-
tion, it is involved in the regulation of growth and dif-
ferentiation during development. Kidney development is
governed by proliferation, differentiation, and apoptosis.
Several isoforms of PKC are expressed during kidney de-
velopment, and inhibition of PKC by a sphingolipid prod-
uct, ceramide, interferes with nephron formation (poor
branching of ureteric buds) and induces apoptosis in the
developing kidney [4]. However, since the molecule that
promotes ureteric bud branching downstream of PKC
was unknown, we performed differential display of PKC-
activated metanephros and PKC-inhibited metanephros
to access a new gene that controls ureteric bud branching
downstream of PKC.
The metanephros-derived tubulogenic factor (MTF)
gene was originally identified as part of a technique in an
mRNA differential display project designed to identify
genes up-regulated by PKC activation in kidney organ
culture. Subsequent cloning and sequencing of the full-
length cDNA revealed a sequence with homology to the
previously reported human CGI-204 cDNA. We exam-
ined the role of this novel gene during renal development
by using antisense oligonucleotides and recombinant pro-
tein in a metanephric organ culture system.
This study investigated a novel gene, MTF, that pro-
motes ureteric bud branching in kidney organ cultures
downstream of PKC.
METHODS
Kidney organ culture
Kidney organ culture was established from mouse em-
bryo as described previously. Embryos were dissected
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from 12 dpc ICR mice. Metanephroi and associated
ureteric buds were microdissected en bloc and cul-
tured on polycarbonate filters (pore size, 1.0 lm)
(Nuclepore, Pleasanton, CA, USA) in serum-free Ham’s
F12:Dulbecco’s modified Eagle’s medium (DMEM) 1:1
(Invitrogen, Carlsbad, CA, USA) medium with the sup-
plements described [5]. After adding the PKC activator
5 nmol/L phorbol 12-myristate 13-acetate (PMA) or the
PKC inhibitor 100 lmol/L N-acetyl-D-sphingosine (C2
ceramide) to the medium, and culturing for 72 hours,
the metanephroi were used in the experiments described
below.
Evaluation of ureteric bud branching and
tubule induction
To visualize ureteric bud growth, cultured whole
metanephroi were fixed with cold methanol for 10 min-
utes, washed three times with phosphate-buffered saline
(PBS) with bovine serum albumin (BSA) (PBST), and
incubated overnight at 4◦C with monoclonal antipancy-
tokeratin antibody (1:50 dilution) (Sigma Chemical Co.,
St. Louis, MO, USA). After washing samples PBST three
times, they were incubated with Cy3-labeled antimouse
IgG (PA) (1:50 dilution) (Jackson Immuno Research
West Grove, PA, USA), again washed with PBST three
times, and examined with a fluorescence microscope. The
degree of branching morphogenesis of the developing
ureteric bud was assessed by counting the number of
terminal ampullae asdescribed by Li et al [6]. To visual-
ize tubule formation, fixed metanephroi were incubated
with fluorescein isothiocyanate (FITC)-conjugated LT
(Lotus tetragonolobus) lectin (1:50 dilution) (Funakoshi,
Tokyo, Japan) for 180 minutes at room temperature. Sam-
ples were washed with PBST three times, mounted, and
examined.
Differential display
TRizol Reagent (Invitrogen) was used to isolate
total RNA from metanephroi treated with PMA or C2 ce-
ramide for 72 hours, and it was exposed to DNase (Takara,
Shiga, Japan). After reverse transcription with oligo-dT
primer (mRNA finger printing kit; Nippon Gene, Tokyo,
Japan), an arbitrary primed polymerase chain reaction
(PCR) was carried out with oligo-dT primer and arbitrary
primers. The thermocycle conditions were: one cycle of
3 minutes at 95◦C, 5 minutes at 40◦C, and 5 minutes
at 72◦C; 24 cycles of 15 seconds at 95◦C, 2 minutes at
40◦C, and 1 minute at 72◦C; and 5 minutes at 72◦C.
The PCR products were separated by a 2% agarose gel
electrophoresis and stained with ethidium bromide. Dif-
ferentially expressed bands were excised from the gel,
eluted, and reamplified by PCR under conditions follow-
ing the procedure described by the supplier. Reampli-
fied PCR products were subcloned into pT7 Blue vector
(Novagen, Madison, WI, USA) with the ligation high
(Toyobo, Tokyo, Japan) and then sequenced. The arbi-
trary primer that yielded a different band of PCR product
was 5-GATCGCATTG-3.
Full-length cDNA cloning and sequencing
We utilized a mouse est cDNA database to estimate
the full-length cDNA based on the 290 bp mouse cDNA
fragment generated by differential display. A 759 bp
full-length cDNA was suspected, and we performed re-
verse transcription (RT)-PCR with mouse embryonic
kidney mRNA with the following primers to obtain it:
forward, 5′-ATGGCTGCGACCAGTCTAGTGGGTA
TT-3′ (MTF-f); reverse, 5′-GACACTACTTGATTTCC
GTTCTTGAGA-3′ (MTF-r). The PCR product was
cloned into pT7 Blue vector (named MTF/pT7Blue) and
sequenced.
RT-PCR and Northern hybridization
After incubating 1 lg of total RNA from the
metanephroi of 12 dpc and 16 dpc mouse or neonatal and
adult mouse kidney with RNase-free DNase, and it was
reverse transcribed into cDNA with random primers and
Moloney-murine mouse virus (Mo-MLV) reverse tran-
scriptase (Invitrogen). The reaction mixture contained
9 pmol random deoxynucleotide hexamers, 1× reverse
transcription buffer, 6.7 mmol/L dithiothreitol (DTT),
0.624 mmol/L desoxynucleoside triphosphate (dNTP),
0.8 units of RNase-OUT, and 4 units Mo-MLV reverse
transcriptase. The reaction was allowed to proceed at
37◦C for 90 minutes, and the cDNA synthesized was used
for PCR. The primers used for developmental RT-PCR
were MTF-f and MTF-r, and they amplified a 759 bp
PCR product. The amplification was performed in a ther-
mal cycler and included 1-minute denaturing at 95◦C,
1-minute annealing at 56◦C, and 1-minute extension at
72◦C. The PCR was run for 28 cycles for MTF/L47 and
23 cycles for b-actin.
The filter for Northern hybridization was purchased
from Clontech (Multiple Tissue Northern Blots, Mouse
MTN Blot; Clontech, Palo Alto, CA, USA) and was hy-
bridized to the probe made with the EcoRI/SalI MTF/pT7
Blue fragment. The Clontech Multiple Tissue Northern
Blots contained oligo-dT–purified mRNA from different
specific normal mouse tissues. The probe was hybridized
to the filter at 62◦C overnight, and after washing the filter
twice with wash solution, BAS 5000 was exposed to it for
60 minutes. After stripping, the same filter was hybridized
to the b-actin probe.
TaqMan PCR
Total RNA was extracted from cultured metanephroi
with TRIzol reagent. Single-strand DNA was generated
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from the RNA by using the TaqMan Reverse Transcrip-
tion Reagents (Applied Biosystems, Foster City, CA,
USA), and the product was used as a template for
real-time PCR by using the ABI Prism 7700 Sequence
Detection System (Perkin-Elmer Applied Biosystems).
Expression of MTF/L47 mRNA was quantitatively de-
termined by using the TaqMan Universal Master Mix
(Applied Biosystems) according to the manufacturer’s
instructions, and standardization was achieved by us-
ing rRNA representation. The primers and TaqMan
probe were designed using the Perkin-Elmer com-
puter program Primer Express. The forward primer
for MTF was GTGCTTGGAGAAGGGACATCT, and
the reverse primer was GAACCGCCTCCTGTTGTAT.
The probe was FAM-TCTGGCACAAATTCAAGCAG
TGGCCTAT. A 50 ng sample of total RNA was used per
reaction, and TaqMan ribosomal RNA Control Reagents
(Perkin-Elmer Applied Biosystems) were used as inter-
nal controls for mRNA expression.
In situ hybridization
For in situ hybridization, metanephroi of 16 dpc mice
were fixed in 4% paraformaldehyde and embedded in
22-oxacalcitriol (OCT) compound (Tissue-Tek, Milano,
Italy). Frozen samples were then cut into 6 lm thick
sections, and the sections were hybridized with cRNA
probes. The cRNA probes were labeled with digox-
igenin and detected with a digoxigenin detection kit
(Boehringer Mannheim, Mannheim, Germany) accord-
ing to the manufacturer’s instructions.
Antisense S-oligonucleotide
To investigate the role of MTF/L47 in kidney devel-
opment, a 20mer antisense S-oligonucleotide (S-ODN)
of MTF/L47, designed to include the first ATG and
scramble S-ODN, were added to organ cultures. Media
containing S-ODNs were prepared by adding 32 lL of
LipofectAmine (Invitrogen) and an antisense S-ODN or
a scramble S-ODN to 40 lL of Opti-MEM (Invitrogen) to
give a final concentration of 8 lmol/L S-ODN in 800 lL,
and then incubating for 45 minutes at room temperature.
The S-ODN/LipofectAmine mixture was then added to
the culture medium to give a final volume of 800 lL.
After 24 hours, the growth medium was replaced with
fresh mixtures prepared as described previously. After
72 hours, cultured metanephroi were analyzed by
immunohistochemistry and RT-PCR.
Synthesize of recombinant protein
RT-PCR was performed for cloning MTF/L47 cDNA
into expressional vector pCDNA 3.1 HisA (Invitrogen).
The primers were: forward, 5′-CATATGGATCCTGG
CTGCGAC-3′ and reverse, 5′-GGGGACTCGAGTGA
CACTACT-3′. The PCR product was digested with
BamHI and XhoI, and the fragment was cloned into
pCDNA 3.1 HisA. MTF/L47 was expressed in a coupled
in vitro transcription-translation system using the TnT-T7
Reticulocyte Lysate System (Promega) by following the
procedure described by the supplier. A 1 lg amount of
plasmid DNA was used in the 50 lL assay. The reaction
mixture was incubated at 30◦C for 90 minutes.
Detection of apoptosis
Apoptotic cells in cultured metanephroi were detected
by a TUNEL method (DeadEnd Fluorometric TUNEL
System; Promega). Cultured metanephroi were fixed and
embedded in OCT compound (Tissue-Tek) as described
previously [5]. Frozen samples were cut into 6 lm thick
sections, and the sections were incubated with equilibra-
tion buffer for 10 minutes at room temperature and then
at 37◦C for 60 minutes with working-strength terminal
deoxynucleotidyl transferase (TdT) reaction buffer. The
reaction was stopped by incubation for 10 minutes in
2× standard sodium citrate (SSC). After washing with
PBS, the sections were incubated with Hoechst 33342
(10 lmol/L) to visualize the nuclei.
[3H]-thymidine incorporation studies
Metanephroi were cultured for 24 hours with or with-
out recombinant MTF/L47 protein, and then exposed
to 25 lCi/mL [3H]-thymidine for 24 hours. Explants
were washed with cold PBS twice and treated with 5%
trichloroacetic acid for 30 minutes at 90◦C [7]. The
hydrolysates were centrifuged, and the supernatants were
counted with a liquid scintillation counter.
RESULTS
PKC activation promotes ureteric bud branching
C2 ceramide inhibited ureteric bud branching in organ
culture as in the previous report, and PMA promoted it
(Fig. 1).
Cloning of MTF/L47
We obtained 20 fragments by the differential display
method, one of which was the KIAA0266 gene product,
and another was the aspartate aminotransferase gene.
We identified a 290 bp product that showed sequence
identity to a mouse est database clone. The est search
revealed a 759 bp full-length cDNA with homology to
human CGI-204. To obtain the full-length cDNA of
mouse MTF/L47, we performed RT-PCR of mouse em-
bryonic kidney mRNA with primers MTF-f and MTF-r,
and a 759 bp PCR product with a sequence identical to
that in the est data base was obtained, and we named it
MTF. MTF/L47 showed high homology to human CGI-
204, and the amino acid homology was 86% (Fig. 2).
MTF/L47 showed homology to drosophilla Rlc1, with
46% amino acid homology.
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Fig. 1. Ureteric bud branching in protein kinase C (PKC)-activated and -inhibited cultured metanephros. (A) Control. (B) Exposure to 5 nmol/L
phorbol 12-myristate 13 acetate (PMA) promoted ureteric bud branching of cultured metanephroi. (C) Exposure to 100 lmol/L C2 ceramide
inhibited ureteric bud branching in organ culture.
Fig. 2. Deduced amino acid sequence of mouse metanephros-
derived tubulogenic factor (MTF/L47). The amino acid sequence of
mPOM210 is available from EMBL/GenBANK/DDBJ under acces-
sion number XP 130843. The human homologue (CGI-204) sequence
(EMBL/GenBANK/DDBJ accession number AAG01157) is written
below the mouse sequence. Human amino acid residues identical to the
mouse residues are shown as dots.
MTF/L47 was increased in cultured
PKC-activated metanephroi
To confirm that MTF/L47 was regulated by PKC
in cultured metanephroi, we performed an RT-PCR
analysis with PMA-treated cultured metanephroi and
C2 ceramide–treated cultured metanephroi. The in-
creased expression of MTF/L47 mRNA in PMA-treated
metanephroi was quantitatively confirmed by the laser
microdissection method (LMM) along with real-time
PCR analysis. The level of MTF/L47 mRNA was greater
in the PMA-treated metanephroi than in C2 ceramide–
treated metanephroi (1.64 ± 0.32 vs. 0.81 ± 0.11 expres-
sion ratio, control was 1.03 ± 0.20, N = 3) (Fig. 3).
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Fig. 3. Mouse metanephros-derived tubulogenic factor (MTF/L47)
expression in protein kinase C (PKC)-activated and -inhibited cul-
tured metanephros. TaqMan reverse transcription-polymerase chain
reaction (RT-PCR) analysis revealed a higher MTF/L47 expression ra-
tio to rRNA in phorbol 12-myristate 13 acetate (PMA)-treated cul-
tured metanephroi than in C2 ceramide-treated cultured metanephroi
(N = 3). (A) Exposure to PMA. (B) Control. (C) Exposure to C2
ceramide.
Developmental expression of MTF/L47 in mouse kidney
Gene expression of MTF/L47 was investigated in
mouse kidney by RT-PCR at various stages of develop-
ment. Strong MTF/L47 expression was observed on E12
and E16, and it was weaker in neonatal and adult kidney
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Fig. 4. Analysis of expression of mouse
metanephros-derived tubulogenic factor
(MTF/L47) by reverse transcription-
polymerase chain reaction (RT-PCR),
Northern blotting, and in situ hybridization.
(A) RT-PCR analysis of expression of
MTF/L47 in fetal and postnatal mouse
kidney. Strong MTF/L47 expression was
observed on E12 and E16, and was weaker
in neonatal and adult kidney. Lane A,
E12; lane B, E16; lane C, P0; and lane D,
adult. (B) Tissue distribution of MTF/L47
mRNA in adult mouse detected by Northern
blotting. Expression of MTF/L47 was high
in the testis, brain, liver, and kidney. (C)
In situ hybridization analysis revealed that
MTF/L47 was expressed mainly in tubules
in the medulla, and it was not expressed in
developing nephrons.
(Fig. 4A), suggesting that MTF/L47 is developmentally
regulated.
In situ hybridization of MTF/L47
Localization of MTF/L47 was restricted to the tubule-
forming cells, and it was not detected in developing
glomeruli (Fig. 4C).
Tissue distribution of MTF/L47 mRNA in adult mice
Several mouse tissues were examined for MTF/L47
mRNA expression by Northern blotting. A single
∼1.0 kbp mRNA transcript was observed on some tis-
sues. Expression of MTF/L47 was high levels in the testis,
brain, liver, and kidney (Fig. 4B). Low level expression
was found in the lung, muscle, spleen, and heart.
Role of MTF/L47 in mammalian metanephrogenesis
We then proceeded to investigate the role of MTF/L47
in metanephric development by utilizing antisense
S-ODN and the organ culture system. The metanephroi
of the explants exposed to antisense S-ODN for 72 hours
exhibited marked changes. There was an overall reduc-
tion in the size of the explants and a marked reduction
in ureteric bud branching (Fig. 5A). By contrast, there
Araki, Hayashi, and Saruta: Cloning of ureteric bud branching promoting gene 1973
Fig. 4. (Continued)
were no differences between scramble S-ODN–treated
metanephroi and control-cultured metanephroi in size or
ureteric bud branching (Fig. 5A). We performed TaqMan
RT-PCR analysis to confirm that the inhibition of ureteric
bud branching was attributable to antisense S-ODN, and
results showed less MTF/L47 mRNA in the antisense
S-ODN–treated metanephroi than in the scramble ODN-
treated metanephroi (0.28 ± 0.13 vs. 1.22 ± 0.39 expres-
sion ratio, N = 3) (Fig. 5B).
Next, we used the recombinant MTF/L47 protein to
investigate the role of MTF/L47 in metanephric de-
velopment in greater detail. The explants exposed to
recombinant MTF/L47 protein for 72 hours exhibited
increased ureteric bud branching (Fig. 6) and increased
LT-lectin–positive structures (Fig. 6). The number of am-
pullae increased from 33.7 ± 3.5 (control) to 48.7 ± 2.5
(recombinant protein) in response to the recombinant
protein (N = 3). We used nonincubated reticulocyte
lysate as a control to eliminate the influence of the reticu-
locyte lysate, and the number of LT-lectin–positive struc-
tures increased 1.3 times in response to the recombinant
protein over the control.
Apoptosis of recombinant MTF/L47
protein–treated metanephroi
Because the recombinant protein-treated metanephroi
were larger than the control metanephroi, we performed
the TUNEL assay, which stains apoptotic cells with
fluorescein-labeled deoxyuridine triphosphate (dUTP).
After 72 hours in culture, metanephroi that have been
exposed to recombinant protein and reticulocyte lysate
were embedded and frozen sectioned. The TUNEL as-
say revealed apoptotic cells among undifferentiated mes-
enchymal cells, but no significant difference was found
between control and recombinant protein (Fig. 7).
Cell proliferation of recombinant MTF/L47
protein–treated metanephroi
Since there was no difference in apoptosis between
the recombinant MTF/L47-treated metanephroi and
the controls, we investigated [3H]-thymidine-associated
incorporation by cultured metanephroi. The total
[3H]-thymidine-associated radioactivity incorporated in
the whole explants was greater in the MTF/L47
recombinant protein-treated kidneys than in the controls
(11343 ± 2412 vs. 18577 ± 6741 cpm/metanephros,
N = 18) (Fig. 8).
DISCUSSION
Cell proliferation, motility, differentiation, and extra-
cellular matrix production are all critical events during
embryonic tissue development. Metanephric kidney de-
velopment is characterized by epithelial cell growth and
differentiation from ureteric buds and induction of the
surrounding mesenchymal cells. Several soluble growth
factors, including hepatocyte growth factor (HGF) [8–
11], glial cell–derived neurotrophic factor (GDNF) [12],
insulin-like growth factors (IGFs) [13, 14], epidermal
growth factors (EGFs) [15, 16], fibroblast growth fac-
tor (FGF) [17], and bone morphogenetic protein-7
(BMP-7) [18], have been thought to be involved in
the mesenchymal-to-epithelial conversion and branching
morphogenesis of ureteric buds. Phosphorylation events
are considered to play crucial roles in determining the
degree of tubule formation during the early development
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of epithelial cells downstream of growth factors. For
example, HGF-mediated induction of branching pro-
cesses in Madin Darby canine kidney (MDCK) cells can
be modulated by multiple phosphorylation mechanisms,
including PKC, PKA, and Ca2+/calmodulin-dependent
kinase [19].
PKC is involved in regulation of the growth and dif-
ferentiation of many organs during development, and
expression of PKC-alpha, -delta, and -zeta in the devel-
oping kidney has been detected by Northern blot analysis
[20]. Ceramide, a sphingolipid implicated in cellular dif-
ferentiation, growth inhibition, and apoptosis, has been
shown to selectively interact with PKC-alpha and -delta
Fig. 5. Metanephros development in vitro assessed by pancyto-
keratin staining with antisense S-oligonucleotide (S-ODN) of mouse
metanephros-derived tubulogenic factor (MTF/L47). (A) Explanted
metanephroi from 12 dpc embryos were grown for 72 hours in a de-
fined medium without S-ODN (control) (A), with scramble S-ODN
(B), or antisense S-ODN (C). There was an overall reduction in the
size of the explants and an extreme reduction in ureteric bud branching
with MTF/L47 antisense S-ODN (D). TaqMan reverse transcription-
polymerase chain reaction (RT-PCR) analysis revealed that antisense
S-ODN inhibited the expression of MTF/L47 mRNA in cultured
metanephroi (N = 3). Lane A, scramble S-ODN; lane B, antisense
S-ODN.
in mesangial cells, and to be capable of inducing apopto-
sis by PKC-alpha inactivation [21]. Addition of ceramide
to metanephric organ culture has been found to induce
apoptosis and impair nephron formation [4].
Although these previous studies pointed to a role of
PKC in renal development, the mediator of the PKC
responses in renal development was unknown. In this
study, we confirmed not only decreased branching in re-
sponse to ceramide, but increased branching in response
to PKC activation by PMA, suggesting the possible ex-
istence of a PKC-related gene that regulates branching
morphogenesis. This led to the identification of a novel
gene, MTF/L47, by the differential display technique.
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Fig. 6. Metanephros development in vitro assessed by pancyto-keratin staining and LT-lectin staining with recombinant mouse metanephros-
derived tubulogenic factor (MTF/L47) protein. Explanted metanephroi from 12 dpc embryos were grown for 72 hours in a defined medium with or
without recombinant MTF/L47. Ureteric bud branching was promoted in the explants treated with recombinant MTF/L47 protein (B) compared
with the control (A). The explants treated with recombinant MTF/L47 protein contained more LT-lectin-positive structures (B) than the control
(A). The number of LT-lectin-positive structures increased from 31.0 per metanephros to 39.9 per metanephros in response to recombinant protein
(N = 9).
Fig. 7. Apoptosis of metanephroi cultured with and without recom-
binant mouse metanephros-derived tubulogenic factor (MTF/L47)
protein. There was no significant difference in apoptosis between
metanephroi cultured with and without recombinant MTF/L47 protein
as assessed TUNEL assay.
RT-PCR analysis showed that MTF/L47 mRNA is
strongly expressed in the embryonic kidney at days 12
and 16, coinciding with the timing of tubulogenesis and
glomerulogenesis.
Metanephros organ culture provides a good model
for investigating kidney morphogenesis and branching.
GDNF significantly increased branching morphogenesis
of the E11.5 metanephros and it induced the formation
of ectopic ureteric buds from the base of the bud and
from the Wolffian duct by enhancing cell survival, and
possibly by increasing proliferation in organ culture [22].
The data from the sequence analysis of MTF/L47 sug-
gested that it was a soluble protein because almost all
the amino acids contained in MTF were hydrophilic. We
then added the recombinant MTF/L47 protein to organ
cultures. Addition of the antisense ODN of MTF/L47
decreased branching of the ureteric bud, whereas addi-
tion of recombinant MTF/L47 increased it. MTF/L47 may
have the ability to promote branching morphogenesis of
renal epithelial cells, the same as GDNF.
Overexpression of PKC-delta and PKC-epsilon in-
duces apoptosis, while overexpression of PKC-alpha in-
hibits the onset of apoptosis via phosphorylation of Akt
on serine 473 [23]. The fact that the metanephroi cultured
with recombinant MTF/L47 protein were larger than the
controls also suggested that the predominant effect of
MTF/L47 might be to prevent apoptosis. However, the
metanephroi cultured with recombinant MTF/L47 pro-
tein showed no marked change in apoptosis as assessed by
the TUNEL method in organ culture. PKC has also been
1976 Araki, Hayashi, and Saruta: Cloning of ureteric bud branching promoting gene
20,000
15,000
10,000
5000
0
Control Exposure to MTF/L47
Fig. 8. Cell proliferation in metanephroi cultured with and without re-
combinant mouse metanephros-derived tubulogenic factor (MTF/L47)
protein. [3H]-thymidine-associated incorporation was measured in
metanephroi cultured with and without recombinant MTF/L47. [3H]-
thymidine-associated incorporated radioactivity was higher in kidneys
exposed to MTF/L47 recombinant protein (N = 18). ∗P < 0.05.
implicated in the proliferation of several types of cells,
and both PKC activation by phorbol ester or lead acetate
and PKC-alpha overexpression increase DNA synthesis
[24–26]. In this study, an increase in thymidine uptake
was observed in metanephroi cultured with recombinant
MTF/L47 protein. Thus, MTF/L47 may play a role in the
cell proliferative function of PKC.
A recent cDNA sequence analysis has shown MTF/L47
to be a homologue of mitochondrial ribosomal protein
L47 [27]. Nearly half of the ribosomal protein transcripts
were found to undergo statistically significant nerve
growth factor (NGF)-promoted alteration in relative
abundance, with changes up to fivefold in PC12 cells [28].
PKC may regulate many ribosomal protein transcrip-
tions, similar to NGF. Some ribosomal proteins undergo
changes in expression in response to various tissue con-
ditions. Heparin/HS interacting protein (HIP/RPL29) is
a small, highly basic, heparin/heparan sulfate interact-
ing protein, identical to ribosomal protein L29, and its
expression depends on the growth/differentiation state
of the luminal epithelium [29]. Recombinant human
HIP/L29 decreased basic FGF-induced proliferation in
fibroblasts from normal gingiva by inhibiting basic FGF
stimulation of mitogen-activated protein kinase (MAPK)
p44 (Erk-1) [30], and apoptosis-related protein [death-
associated proteins (DAP3)] has been shown to be a
ribosomal protein [31, 32]. Thus, there may be other ri-
bosomal proteins that control not only apoptosis but also
cascades of growth factors, the same as HIP/PRL29, and
MTF/L47 may be one of them.
The pathway by which MTF/L47 induced cell pro-
liferation in the metanephroi was not identified in the
present study, and it is also unknown whether endoge-
nous MTF/L47 produced the by metanephros is secreted
into the extracellular fluid. The precise characteristics of
this protein should be determined in future studies.
CONCLUSION
We identified a novel gene, MTF/L47, by differen-
tial display and demonstrated that MTF/L47 is capa-
ble of regulating kidney development by controlling cell
proliferation.
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